On Tuesday, Shares of Netflix, Inc. (NASDAQ:NFLX), surged 7.63% to $121.15, hitting its highest level.
Netflix is giving new parents on its payroll up to a year of paid leave in a move that could pressure other technology employers to improve their baby benefits as they vie for talent, according to AP.
The employee benefit declared Tuesday on Netflix’s blog is generous even by the high standards of Silicon Valley, where free meals and other perquisites supplement lavish salaries in the fiercely competitive battle for computer programmers and other technology workers. AP Reports.
Netflix, Inc., an Internet television network, engages in the Internet delivery of TV shows and movies directly on TVs, computers, and mobile devices in the United States and internationally. The company operates in three segments: Domestic Streaming, International Streaming, and Domestic DVD. It also provides DVDs-by-mail membership services.
Shares of Integrated Device Technology, Inc. (NASDAQ:IDTI), inclined 5.66% to $20.15, during its last trading session.
Integrated Device Technology declared results for the fiscal first quarter ended June 28, 2015.
“First quarter fiscal 2016 revenue raised by more than 27 percent year-over-year, driven primarily by strength in our High Performance Computing and Wireless Power products,” said Greg Waters, president and chief executive officer. “We are delivering on our commitment of superior earnings leverage with growth, and are happy to declare a non-GAAP operating margin of 29.3 percent for the quarter.
“As we look out to the rest of fiscal 2016, we are confident in our ability to meaningfully outgrow the semiconductor market. Our new product design-win traction is very high, and we are in the early stages of delivering new classes of products in all three of our target market segments” concluded Mr. Waters.
Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of semiconductor solutions for the communications, computing, and consumer industries worldwide. It operates in two segments, Communications, and Computing and Consumer.
Finally, Boston Scientific Corporation (NYSE:BSX), ended its last trade with -0.12% loss, and closed at $17.09.
Boston Scientific Corporation has closed on the formerly declared agreement with Endo International plc (ENDP) (ENL.TO) to purchase American Medical Systems’ (AMS) Men’s Health and Prostate Health businesses, for $1.6 billion in up-front cash and a potential additional $50 million milestone based on 2016 sales. The acquisition positions Boston Scientific as a leader in urology, providing physicians and healthcare systems a comprehensive portfolio of proven technologies.
The transaction comprises AMS’ leading products for treating urologic conditions, counting the minimally invasive GreenLight XPS™ and HPS™ Laser Therapy Systems for treating benign prostatic hyperplasia, the AMS 800™ Urinary Control System for treating male incontinence and the AMS 700™ Inflatable Penile Prosthesis for treating erectile dysfunction. These technologies complement the Boston Scientific leading urology portfolio for the treatment of kidney stones and pelvic floor disorders, enabling further innovation for the company across five common urologic diseases that account for 50 percent of all urologic surgical procedures. The AMS women’s health business is not part of the transaction.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Administration, and MedSurg.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
